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Dietary treatment with high-fat diets (HFD) triggers diabetes and hyperleptinemia, con-
comitantly with a partial state of leptin resistance that affects hepatic and adipose tissue
but not the heart. In this context, characterized by widespread steatosis, cardiac lipid con-
tent remains unchanged. As previously reported, HFD-evoked hyperleptinemia could be a
pivotal element contributing to increase fatty-acid (FA) metabolism in the heart and to
prevent cardiac steatosis. This metabolic adaptation might theoretically reduce energy
efficiency in cardiomyocytes and lead to cardiac electrophysiological remodeling. There-
fore the aim of the current study has been to investigate the impact of long-term HFD
on cardiac metabolism and electrophysiological properties of the principal ionic currents
responsible of the action potential duration in mouse cardiomyocytes. Male C57BL/6J
mice were fed a control (10 kcal% from fat) or HFD (45 kcal% from fat) during 32 weeks.
Quantification of enzymatic activities regulating mitochondrial uptake of pyruvate and FA
showed an increase of both carnitine-palmitoyltransferase and citrate synthase activities
together with a decrease of lactate dehydrogenase and pyruvate dehydrogenase activities.
Increased expression of uncoupling protein-3, Mn-, and Cu/Zn-superoxide dismutases and
catalase were also detected. Total glutathione/oxidized glutathione ratios were unaffected
by HFD.These data suggest that HFD triggers adaptive mechanisms aimed at (i) facilitating
FA catabolism, and (ii) preventing oxidative stress. All these changes did not affect the dura-
tion of action potentials in cardiomyocytes and only slightly modified electrocardiographic
parameters.
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INTRODUCTION
Obesity develops in a complex scenario characterized by an altered
adipokine profile associated to systemic low-grade inflammation
and, often, to diabetes (1, 2). There is now compelling evidence
that an altered pattern of adipokine release together with insulin
resistance are main causes of heart metabolism remodeling and
cardiac disease in obese individuals (3–6). Nevertheless the fact
that insulin resistance is not systematically present in obese indi-
viduals makes difficult to identify the link between obesity and
cardiomyopathy (2, 7). Previous research of our group has evi-
denced the up-regulation of enzymatic activities involved in fatty-
acid (FA) catabolism in cardiac tissue of diet-induced obese (DIO)
mice (8, 9). These metabolic changes might be linked to a particu-
lar endocrine environment characterized by hyperleptinemia and
be protective for cardiac tissue as they might account for the lack
of cardiac steatosis observed in these animals (10, 11). It has to be
noted that the experimental model used in these former studies
is based on an eight-month HFD treatment schedule in mice that
were 5-week-old when treatment started, and deals with elevated
HOMA-IR indexes and widespread leptin resistance that affects
most tissues except the heart. Interestingly, we have observed that a
high HOMA-IR index is an insufficient condition to cause hepatic
steatosis in absence of hepatic resistance to leptin (10).
Although FA are the main source of energy in cardiac tissue, an
overload of dietary fat has been shown to promote mitochondrial
β-oxidation to the detriment of pyruvate catabolism. FA oxidation
is less efficient than glucose/pyruvate in terms of energy produc-
tion because FA consume more oxygen than glucose does (12–14)
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and they can be ejected from mitochondria by means of the uncou-
pling protein-3 (UCP3), leading to a mitochondria-cytosol futile
FA cycling (15). Otherwise, excessive FA oxidation has been shown
to increase citrate production which can inhibit phosphofruc-
tokinase, a key enzyme recruiting fructose-6-phosphate into the
glycolytic pathway, and also impair pyruvate oxidation (16–18).
Finally, under these conditions, the rate of reactive oxygen species
(ROS) production can be increased (19), and cause mitochondrial
damage (20). In fact, optimizing energy metabolism by increasing
glucose oxidation has been proposed to be an useful approach to
prevent and treat cardiac dysfunction in obese people (15) as well
as a valuable therapeutic intervention in failing hearts (3, 21, 22).
The aim of the current study was to further characterize the
influence of long-term DIO on cardiac metabolism and the even-
tual association of metabolic remodeling and cardiac electrophys-
iological properties. For this purpose, we have analyzed in hearts
of DIO mice: (i) enzymatic activities of lactate dehydrogenase,
pyruvate dehydrogenase, carnitine-palmitoyltransferase (CPT),
and citrate synthase (CS), as well as lactate content, (ii) mito-
chondrial uncoupling, (iii) redox status, (iv) electrophysiological
properties of ionic currents responsible for the action potential
duration (APD) in cardiomyocytes, and (v) electrocardiographic
characteristics.
MATERIALS AND METHODS
EXPERIMENTAL DESIGN
Five-week old male C57BL/6J mice (Harlan, Spain) were housed
(five per cage) under a 12 h light/12 h dark cycle, in a temperature-
controlled room (22°C) with food and water ad libitum. Animals
were divided in two groups with similar average BW and assigned
either to a control or to a high-fat diet (HFD). Control diet
(D12450B, 10 kcal% fat, 70 kcal% carbohydrates, and 20 kcal%
protein; 3.85 kcal/g) and HFD (D12451, 45 kcal% fat, 35 kcal%
carbohydrates, and 20 kcal% protein; 4.73 kcal/g) were supplied
by Test Diet Limited BCM IPS Ltd (UK). After 32 week dietary
treatment, groups of animals were separated for biochemical and
functional studies. The investigation conforms to the Guide for
the Care and Use of Laboratory Animals published by the US
National Institute of Health (NIH publication No. 85–23, revised
1996). This study was approved by the ethics committee of the
University CEU-San Pablo (SAF 2009-09714).
PLASMA BIOCHEMISTRY
Animals were killed by decapitation between 9 and 10 a.m., blood
collected in chilled EDTA-coated polypropylene tubes and left
ventricle dissected and frozen. Plasma samples were stored at
−80°C until assay. For enzymatic activities, tissues were imme-
diately processed and prepared for assay. Proteins, lactate, and
glutathione were determined in frozen tissues. Plasma leptin
(Linco Research, USA; 4.9% intra-assay variation, 3.3% inter-
assay variation) and insulin (Mercodia,Denmark; 2.2% intra-assay
variation, 4.9% inter-assay variation) were quantified by specific
radioimmunoassay and ELISA, respectively.
CARDIAC TRIGLYCERIDES
Triglyceride content in heart was determined as previously
described (8). Briefly, 20 mg of wet tissue were homogenized in
a mixture containing 40 ml of 2 mM NaCl/20 mM EDTA/50 mM
sodium phosphate buffer (pH 7.4) 40 ml of tert-butanol, and 20 ml
of Triton X-100/methanol (1/1). Triglycerides were measured with
a Sigma diagnostic kit (USA).
QUANTIFICATION OF PROTEINS BY WESTERN-BLOT
We quantified uncoupling protein-1, 2, and 3 (UCP1, UCP2,
UCP3, respectively) Mn- and Cu/Zn-superoxide dismutase (Mn-
SOD, Cu/Zn-SOD), and catalase. Western-blotting was performed
as previously described (8, 9). Briefly, primary antibodies against
UCP1, UCP3 (Affinity BioReagent, USA), UCP2 (Santa Cruz Bio-
thecnology, USA), and Mn-SOD, Zn-SOD, and catalase (Sigma,
USA) were applied overnight at 4°C at the appropriate dilution.
After washing and incubation with appropriate IgG-peroxidase
complexes, blots were incubated in commercial enhanced chemi-
luminescence reagents (ECL, Amersham Bioscence, UK) and
exposed to autoradiographic film. Films were scanned using a
GS-800 Calibrated Densitometer (Bio-Rad, Spain) and quan-
tified using Quantity One software (Bio-Rad, Spain). Values
were normalized with β-actin to account for variations in gel
loading.
DETERMINATION OF ENZYMATIC ACTIVITIES
Lactate dehydrogenase, CPT, CS, and pyruvate dehydrogenase
activities were measured by means of colorimetric methods as
described in the literature (8, 9, 23, 24). Glucose-6-phosphate
dehydrogenase (G6PD) activity was determined by measuring
∆ absorbance at 340 nm (Versamax, Molecular Devices, USA)
due to the conversion of NADP+ to NADPH by G6PD and
6-phosphogluconate-dehydrogenase (6PGD). For total activity
(G6PD and 6PGD), samples (1 mg/ml protein) were incubated
in 96-well microplates containing assay buffer (50 mM Tris
pH= 8.1, 1 mM MgCl2, 0.2 mM glucose-6-phosphate, 0.2 mM
6-phosphogluconate, and 0.1 mM NADP+). For 6PGD activity
determination, samples were incubated in absence of glucose-6-
phosphate and then G6PD activity theoretically estimated by sub-
tracting 6PGD activity from total activity. Results were expressed
as ∆ Abs/min/mg protein (25).
DETERMINATION OF SUPEROXIDE ANION, GLUTATHIONE AND LACTATE
Production of superoxide anion (O−2 ) was determined in fresh
samples by measuring lucigenin-enhanced chemiluminescence
(26, 27). Briefly, heart explants were incubated for 30 min at 37°C
in oxygenated 20 mM HEPES buffer (pH= 7.4, 99 mM NaCl,
4.7 mM KCl, 1.9 mM CaCl2, 25 mM NaHCO3, 1 mM KH2PO4,
1.2 mM MgSO4, 11 mM glucose). Explants, NADPH (1 mmol/l)
and lucigenin (5µmol/l) were then added to tubes containing
1 ml buffer. O−2 production was expressed in arbitrary units/mg
protein. Lactate concentration was measured as described (8).
For glutathione assay, samples were homogenized in phosphate
buffer (pH= 6–7) containing EDTA (1 mM) and centrifuged for
15 min (10,000 g ; 4°C). Supernatants were collected and kept
at −20°C until assay. Both reduced (GSH) and oxidized glu-
tathione (GSSG) concentrations were quantified by colorimetric
assay by using a commercial kit (Cayman Chemical, USA) follow-
ing the manufacturer instructions. Data were expressed as (total
glutathione)/(GSSG).
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ISOLATION OF VENTRICULAR MYOCYTES
Mice were heparinized (1 IU/kg i.p.) and anesthetized with pen-
tobarbital (50 mg/kg). Hearts were rapidly dissected, mounted
on a modified Langendorff apparatus and retrogradely perfused
through the aorta (2–3 min, 36–37°C) with Ca2+-free Tyrode
solution (TS; 130 mM NaCl, 5.4 mM KCl, 0.4 mM NaH2PO4,
0.5 mM MgCl2, 25 mM HEPES, 5 mM NaHCO3, 22 mM glu-
cose; pH adjusted to 7.4 with NaOH) containing 0.2 mM EGTA,
then 3–4 min with TS containing 251 IU/ml type II collagenase
(Worthington, USA), and 0.1 mM CaCl2. After perfusion, hearts
were chopped in small pieces, and gently stirred in TS containing
1 mg/ml bovine serum albumin (BSA, Sigma, USA). Isolated cells
were filtered, centrifuged and suspended in TS containing 2 mg/ml
BSA and 0.5 mM CaCl2. After centrifugation, cells were suspended
in a solution containing 1 mM CaCl2 and 2 mg/ml BSA and stored
at room temperature until electrophysiological assays (within 5 h
of the isolation).
CELLULAR ELECTROPHYSIOLOGY
Electrophysiological experiments were performed at room tem-
perature (24–26°C) on Ca2+-tolerant rod-shaped myocytes.
Whole-cell configuration of the patch-clamp technique was
employed to measure the L-type Ca2+ current (ICaL), the transient
outward K+ current (Itototal), the ultra-rapid delayed rectifier K+
current (IKur), and the steady-state outward K+ current (I ss). The
voltage-clamp circuit was provided by an Axopatch-200B ampli-
fier controlled by a computer equipped with a pClamp 6.0 and
interfaced to the amplifier with a Digidata 1322A (Axon Instru-
ments, USA). Recording pipettes were made from 1.5 mm-OD
soft-glass capillary tubing by using a microprocessor-based patch-
clamp puller (P97/PC, Sutter Instruments, USA). Tip resistances
after filling with the internal solution ranged between 0.9–2 MΩ.
Whole-cell currents were expressed as current densities, which
were calculated from the current amplitude normalized by the
membrane capacitance. Membrane capacitance (Cm) was calcu-
lated according to the equation Cm= τc I 0/∆Em [1− (I∞/I 0)]
(τc, time constant of the membrane capacitance; I 0 maximum
capacitance current value; ∆Em, amplitude of the voltage step;
I∞, amplitude of the steady-state current). Cm was elicited
by applying ±10 mV voltage steps from a holding potential of
−60 mV. Current-voltage (I −V ) relationship for the ICaL was
obtained from a holding potential of –50 mV and cell depolariza-
tion (300 ms, 0.2 Hz) in 10 mV increments from −40 to +60 mV.
Current-voltage (I −V ) relationship for Itototal was constructed
from 500 ms series test potentials varying from −70 to +50 mV
in 10 mV increments, from a holding potential of −80 mV at a
frequency rate of 0.1 Hz. The same protocol was applied but now
preceded by a 100 ms inactivating pre-pulse (−40 mV) in order to
suppress the transient portion of the Itototal (28). The remaining
current (IKslow) is composed of both a IKur (4-aminopyridine-
sensitive component) and a I ss (4-aminopyridine-resistant com-
ponent). For I ss recording, an inactivating pre-pulse was applied
in presence of 250µM 4-AP. IKur was calculated by subtracting
I ss from the current recorded in the absence 4-AP. Current densi-
ties were determined at the peak current. Action potentials (AP)
were elicited at 10 s intervals by 1.5-fold excitation threshold cur-
rent pulses of 2.5 ms in duration. After stabilization of the records,
10 successive APs were recorded. The parameters of the APs for
each cell corresponded to the mean of these 10 APs. The APD
was measured at 20, 50, and 90% repolarization. The solution for
ICaL recording contained (in mM): 140 NaCl, 1.1 MgCl2, 5.4 CsCl,
10 glucose, 5 HEPES, 1.8 CaCl2; pH adjusted to 7.4 with NaOH.
The intracellular recording pipette solution for whole-cell exper-
iments contained (in mM): 100 CsCl, 20 triethylamine, 5 EGTA,
10 HEPES, 5 Na2ATP, 0.4 Na2GTP, 5 Na2creatine phosphate, 0.06
CaCl2; pH adjusted to 7.4 with CsOH. The solution for K+ current
recordings contained (in mM): 135 NaCl, 10 glucose, 10 HEPES,
1 MgCl2, 1 CaCl2, 5.4 KCl, 1 CoCl2, 1 BaCl2 (250µM 4-AP),
pH adjusted to 7.4 with NaOH. The solution for AP recordings
contained (in mM): 140 NaCl, 4 KCl, 1.1 MgCl2, 1.8 CaCl2, 10
glucose, 10 HEPES, pH adjusted to 7.4 with NaOH. The intracel-
lular recording pipette solution for both Ito and AP contained (in
mM): 135 KCl, 4 MgCl2, 5 EGTA, 10 HEPES, 10 glucose, 5 Na2ATP,
3-phosphocreatine, pH adjusted to 7.2 with KOH.
SURFACE ELECTROCARDIOGRAM RECORDINGS
Mice were anesthetized with sodium pentobarbital (60 mg/kg).
Thirty two-gauge needle steel electrodes were inserted subcuta-
neously, according to a standard three-lead ECG scheme. Acqui-
sition was performed during 8–10 min following anesthesia and
data collected for 8–15 consecutive min at a rate of 4 kHz
by using a ML136 Animal Bio amplifier. Parameters for each
individual animal were calculated from 40 to 45 consecutive
traces (LabChart 47.0 Pro, ADInstruments, UK). QTc interval
was calculated using a modified Bazzett’z correction formula
[QTc=QT/(RR/100)1/2 (29)].
STATISTICS
All parameters were analyzed by a one-way ANOVA, followed
by Newman-Keuls post hoc test. Statistical significance was set at
p< 0.05.
RESULTS
PLASMA BIOCHEMISTRY AND CARDIAC WEIGHT AND LIPID CONTENT
As summarized in Table 1, HFD animals displayed a 40%
increase BW, compared to control animals (p< 0.001). Heart
weight was increased approx. about 7% in HFD mice (p< 0.05),
although cardiac TGs were not different between control and HFD
groups. Plasma insulin (p< 0.001) and leptin (p< 0.05) were also
increased by HFD treatment.
ENZYMATIC ACTIVITIES INVOLVED IN MITOCHONDRIAL UPTAKE OF
FATTY-ACIDS AND PYRUVATE APPEAR TO BE UP- AND
DOWN-REGULATED, RESPECTIVELY, IN HFD MICE
We observed that both lactate dehydrogenase [F (1,21)= 5.717;
p< 0.05; Figure 1A] and pyruvate dehydrogenase activities
[F(1,8)= 12.479; p< 0.001; Figure 1B] were reduced in HFD mice.
This suggests that the contribution of lactate and pyruvate to car-
diac energetics would be reduced in HFD mice. Moreover, as pre-
viously reported (9), 1-way ANOVA revealed an increase of total
CPT activity in HFD mice [F (1,18)= 15,417; p< 0.05; Figure 1C],
suggesting that mitochondrial uptake of FA is up-regulated by
HFD treatment.
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Table 1 | Effect of 32-week HFD on body and cardiac weight, cardiac triglyceride content, and insulin and leptin plasma concentration.
BW (g) Heart weight (mg) Cardiac triglycerides (mg/g tissue) Plasma insulin (µg/l) Plasma leptin (ng/ml)
Control 33.9±0.6 160.4±3.1 33.5±3.6 1.9±0.2 12.8±1.9
HFD 47.1±1.1*** 175.2±6.1* 27.8±2.6 6.0±0.7*** 30.2±4.5*
*p<0.05; ***p<0.001 (Newman–Keuls’s test).
FIGURE 1 | Enzymatic activities. Effect of HFD on cardiac lactate
dehydrogenase (LDH) (A), piruvate dehydrogenase (PDH) (B),
carnitine-palmitoyltransferase (CPT) (C), and citrate synthase (CS) (D)
activities. Results are expressed as mean±SEM. Statistical analyses were
performed with one-way ANOVA followed by a Newman-Keuls test.
*p<0.05, ***p<0.001, compared with the control group.
CITRATE SYNTHASE ACTIVITY AND MITOCHONDRIAL UNCOUPLING
The ability of cardiac mitochondria to incorporate acetyl-CoA
to the tricarboxylic acid cycle can be estimated by measuring CS
activity, which accounts for the condensation of acetyl-CoA and
oxaloacetic acid to yield citric acid. Figure 1D illustrates the effect
of HFD on CS activity, which was significantly increased in HFD
mice [1-ANOVA F (1,10)= 5,349; p< 0.05]. This up-regulation
corresponds to almost 30% increase of CS activity. We determined
the amount of UCP1, UCP2 (data not shown), and UCP3 and
only UCP3 (Figure 2) appeared to be up-regulated in HFD mice
[1-ANOVA F (1,12)= 5,327; p< 0.05].
REDOX STATUS OF CARDIAC TISSUE AFTER HFD TREATMENT
Cu/Zn-SOD, Mn-SOD, and catalase were increased in the
HFD group [1-ANOVA F (1,11)= 5.593, p< 0.05; 1-ANOVA
F (1,10)= 5.017, p< 0.05; 1-ANOVA F (1,10)= 5.141, p< 0.05
respectively; see Figures 3A–C. (Total glutathione)/(Oxidized glu-
tathione) ratios were not different between control (7.69± 1.21)
and HFD animals (7.76± 1.69). O−2 production appeared to be
slightly increased (p= 0.08) in HFD mice (Figure 3D). Finally,
we observed a reduction of glucose-6-phosphate dehydrogenase
activity (Figure 3E). This enzyme is a main source of NADPH, a
co-factor necessary for maintaining redox equilibrium.
CELLULAR ELECTROPHYSIOLOGY
To analyze the influence of HFD in the cellular electrophysio-
logical properties of ventricular myocytes, patch-clamp experi-
ments were carried-out. Figure 4A shows that mean APD val-
ues, measured at 20, 50, and 90% repolarization, were iden-
tical in control and HFD ventricular myocytes. Figure 4B
shows current density-voltage relationship for ICaL obtained in
myocytes isolated from control and HFD mice. The maximum
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value of ICaL density was −7.8± 0.7 pA/pF at 0 mV (n= 10)
for control and −7.0± 0.7 pA/pF at 0 mV (n= 9) for HFD
mice. Figure 4C illustrates current density-voltage relationships
FIGURE 2 | Mitochondrial uncoupling. Effect of a HFD on protein
expression of cardiac UCP3. Diagram bars show the result of densitometric
analysis of UCP3 immunoblots, expressed as percentage of UCP3 in the
control group. Data are presented as mean±SEM. *p<0.05 compared
with the control group.
for K+ currents (Itototal, I kur, and I ss). Mean density values
and voltage-dependence were similar between control and HFD
myocytes. Itototal at +60 mV was 23.4± 4.6 pA/pF (n= 10) for
control and 22.0± 3.1 pA/pF (n= 10) for HFD. I kur at +60 mV
was 15.1± 4.2 pA/pF (n= 9) for control and 15.3± 3.6 pA/pF
(n= 7) for HFD. I ss at +60 mV was 10.5± 0.9 pA/pF (n= 9)
for control and 10.1± 0.9 (n= 7) for HFD. Taken together these
data indicate that HFD did not induce changes in the cellular
electrophysiological properties of ventricular myocytes.
HFD MICE EXHIBITED SIMILAR ELECTROCARDIOGRAPHIC RECORDINGS
THAN CONTROL ANIMALS
Figure 5 illustrates typical examples of ECG recordings in con-
trol and HFD mice. Heart rates were similar between groups. In
addition, QRS complexes, QT, and T wave duration were sim-
ilar between groups, reflecting a normal velocity of ventricular
depolarization/repolarization. PR intervals were slightly shorter
(p< 0.05) in HFD than in control animals.
DISCUSSION
This study shows that long-term HFD activates metabolic path-
ways in cardiac tissue that would (i) promote β-oxidation to the
detriment of carbohydrate catabolism, and (ii) prevent cardiac
steatosis. This is striking inasmuch as under our experimental
conditions both adipose and hepatic tissues undergo pathological
alterations of energy metabolism leading to obesity and hepatic
steatosis The interest of our animal model (long-term treatment
with a relatively mild, 45% kcal from fat, HFD from the early
adolescence) deals with the fact that HFD mice display diabetes,
FIGURE 3 | Redox status in cardiac tissue. Effect of a HFD on protein
expression of cardiac Cu/Zn-SOD (A), Mn-SOD (B) and catalase (C),
superoxide anion (O−2 ) production (D), and glucose-6-phosphate
dehydrogenase activity (E). Diagram bars show the result of densitometric
analysis of immunoblots, expressed as percentage of Cu/Zn-SOD, Mn-SOD,
and catalase in the control group. Results are presented as mean±SEM of
6–8 animals/group. *p<0.05, **p< 0.01, ***p<0.001 compared with the
control group.
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FIGURE 4 | Electrophysiological properties of ventricular adult myocytes
isolated from mice fed with control (open bars) or high-fat diet (HFD)
(solid bars) during 32weeks. (A) Mean action potential duration (APD)
values measured at 20, 50, and 90% of repolarization (APD20, APD50, and
APD90) in adult myocytes isolated from control and HFD mice (B) Current
density-voltage relation of l-type calcium current (ICaL) obtained in adult
myocytes isolated from control and HFD mice. (C) Current density-voltage
relations of three different K+ currents obtained in adult myocytes isolated
from control and HFD mice: transient outward K+ current (Itototal), the
ultra-rapid delayed rectifier K+ current (Ikur), and the steady-state outward K+
current (Iss). Statistical analyses were performed using unpaired Student’s
t -test.
obesity, and hyperleptinemia together with a generalized state of
leptin resistance that does not involve cardiac tissue (10). This is a
very relevant issue because the above mentioned study evidenced
that ectopic deposition of lipids in the liver of obese mice is coin-
cident with the development of leptin resistance in this organ. In
fact, many authors have reported that HFD causes cardiac steato-
sis in genetically engineered models of obesity dealing with either
generalized leptin resistance or aleptinemia (15, 30–32). Thus, the
current data would further support the concept that a particular
responsiveness of cardiac tissue to hyperleptinemia might account
for the adaptive metabolic remodeling triggered by HFD. Other-
wise, although a systematic analysis of heart morphology has not
been carried-out, cardiac hypertrophy seems to be absent (car-
diac weight appears to be only slightly increased in HFD mice, but
appears to be decreased when comparison is made between car-
diac weight/BW ratios). Moreover, we have observed that cardiac
electrophysiology remains mostly unaffected suggesting that 45%
HFD treatment are less detrimental for the heart than for other
tissues such as the liver (10) or, even, the central nervous system
(33, 34).
In our previous study we had characterized the influence of
HFD on the kinetic characteristics of cardiac CPT and we had
found that DIO reduces the inhibitory effect of malony-CoA on
CPT activity by a mechanism involving the Akt signaling pathway
(9). This former study strongly supports the concept that cardiac
metabolism adapts to HFD by increasing mitochondrial uptake
and further oxidation of FA. In the current study we have evaluated
enzymatic activities involved in glucose metabolism and we have
identified a decrease of both lactate dehydrogenase and pyruvate
dehydrogenase activities together with a reduction of lactate con-
centration that suggests a low glycolytic rate as well as a small con-
tribution of pyruvate to mitochondrial energy supply. In addition,
the elevated CS activity detected in HFD mice suggests an increased
production of citrate, which would act as an allosteric inhibitor of
phosphofructokinase, the enzyme recruiting glucose-6-phosphate
for the glycolytic pathway (16–18). Moreover, increased citrate
production would be coherent with an elevated rate of β-oxidation
(18). Otherwise, the activity of glucose-6-phosphate dehydroge-
nase activity appears to be reduced in HFD mice, suggesting that
NADPH levels might be reduced by the dietary treatment. The
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FIGURE 5 | Electrocardiogram recordings and interval values obtained in control and HFD mice. Typical surface ECG recording obtained in control (A) and
HFD mice (B). Intervals duration and heart rate appear summarized in table (C). *p<0.05, compared to the control group. HR, heart rate.
eventual consequences of a fall of NADPH levels are difficult to be
drawn as this co-factor is pivotal to maintain the pool of reduced
glutathione for reductive process but it is also the substrate of
NADPH-oxidase, a source of O−2 and ROS production. In fact, O
−
2
levels appears to be slightly increased in HFD hearts while (total
glutathione)/(oxidized glutathione) ratios appear to be unchanged
by HFD. Otherwise we have detected an up-regulation of antiox-
idant enzymes. Taken together, all these data would indicate that
cardiac tissue of HFD mice remain mostly unaffected in terms of
oxidative stress.
Finally we have also explored the effect of HFD on the amount
of the uncoupling proteins UCP1, UCP2, and UCP3. In our study
UCP3 is the only UCP that appears to be over-expressed in HFD
mice. In a recent study Boudina et al. (35) have reported that
UCP3 is up-regulated by HFD. These authors propose that UCP3
could be a negative regulator of cardiac efficiency in using energy
derived from FA oxidation, although UCP3 lacks of effect on FA
oxidation rates. Otherwise, UCP3 might act as a proton leaker and
might also facilitate the translocation of FA carboxylate anions
out of the mitochondrial matrix. Because carboxylates re-enter
the mitochondria as neutral (protonated) species (36), the up-
regulation of UCP3 might generate a futile cycling of FA that
would contribute to reduce ATP synthesis. In this context, our
results would suggest that HFD hearts might display poor energy
efficiency. In fact ATP levels appear to be decreased in HFD hearts
(0.25± 0.03 in HFD vs. 0.40± 0.05 nmol/mg protein in control
animals; p< 0.05; results not shown), although this data is of dif-
ficult interpretation in absence of AMP and/or creatinphosphate
values. From our data we cannot draw the mechanism that account
for UCP3 up-regulation, but we hypothesize that hyperleptinemia
might play a role. Interestingly, the former study by Boudina et al.
(35) has evidenced that the energy-wasting function attributed to
UCP3 is not perceptible in aleptinemic mice, and leptin has been
shown to induce UCP3 in different tissues (37, 38). Our data sug-
gest that UCP3 up-regulation would be integral to the adaptive
response to HFD/hyperleptinemia, that would contribute to spare
ectopic lipid deposit even at expense of a loss of energy efficiency.
Although functional studies are necessary to characterize car-
diac function in DIO mice, our data suggest that HFD trigger an
efficient metabolic adaptation, able to avoid ectopic accumulation
of triglycerides and to limit lipotoxic damage (31), which include
the preservation of cardiac electrophysiological properties of the
major ionic currents, as already reported to occur in DIO rats (39).
K+-current remodeling has been observed in metabolic cardiomy-
opathy induced by PPARα overexpression, supporting the concept
that myocardial metabolism and cardiac function are closely linked
(40). The shortening of PR intervals detected in the current study is
compatible with the existence of accessory atrio-ventricular path-
ways and suggests that, in spite of a normal behavior of ventricular
K+-channels, conduction abnormalities might be incipient. To our
knowledge, this is the first study showing that a dietary treatment
is able to evoke this kind of conduction alteration. Interestingly,
this kind of accessory pathways is present at birth in humans (41)
and normally disappears few weeks after birth. Nevertheless, they
appear to be preserved in adult hearts lacking normal AMPK activ-
ity (42). We have previously reported that the active form of AMPK
is less abundant in DIO than in control hearts (9) and we speculate
now that a HFD treatment from early adolescence might induce de
novo development of cardiac accessory pathways or, alternatively,
to delay the natural degeneration of perinatal atrio-ventricular
www.frontiersin.org November 2013 | Volume 4 | Article 175 | 7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Guzmán-Ruiz et al. Hyperleptinemia, cardiac metabolism, and electrophysiology
connections. It has to be noted that ECG recordings were per-
formed in anesthetized animals and, therefore, eventual effects of
the anesthesia cannot be discarded.
In conclusion, all these results indicate that metabolic remod-
eling evoked by HFD appears to be insufficient to affect cardiomy-
ocyte electrical properties, but could trigger incipient functional
disorders.
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